Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Mar 27;78(13):998-1006.
doi: 10.1212/WNL.0b013e31824d587f. Epub 2012 Mar 14.

A comparison of nine scales to detect depression in Parkinson disease: which scale to use?

Affiliations
Randomized Controlled Trial

A comparison of nine scales to detect depression in Parkinson disease: which scale to use?

J R Williams et al. Neurology. .

Abstract

Objective: The Methods of Optimal Depression Detection in Parkinson's Disease (MOOD-PD) study compared the psychometric properties of 9 depression scales to provide guidance on scale selection in Parkinson disease (PD).

Methods: Patients with PD (n = 229) from community-based neurology practices completed 6 self-report scales (Beck Depression Inventory [BDI]-II, Center for Epidemiologic Studies Depression Rating Scale-Revised [CESD-R], 30-item Geriatric Depression Scale [GDS-30], Inventory of Depressive Symptoms-Patient [IDS-SR], Patient Health Questionnaire-9 [PHQ-9], and Unified Parkinson's Disease Rating Scale [UPDRS]-Part I) and were administered 3 clinician-rated scales (17-item Hamilton Depression Rating Scale [HAM-D-17], Inventory of Depressive Symptoms-Clinician [IDS-C], and Montgomery-Åsberg Depression Rating Scale [MADRS] and a psychiatric interview. DSM-IV-TR diagnoses were established by an expert panel blinded to the self-reported rating scale data. Receiver operating characteristic curves were used to estimate the area under the curve (AUC) of each scale.

Results: All scales performed better than chance (AUC 0.75-0.85). Sensitivity ranged from 0.66 to 0.85 and specificity ranged from 0.60 to 0.88. The UPDRS Depression item had a smaller AUC than the BDI-II, HAM-D-17, IDS-C, and MADRS. The CESD-R also had a smaller AUC than the MADRS. The remaining AUCs were statistically similar.

Conclusions: The GDS-30 may be the most efficient depression screening scale to use in PD because of its brevity, favorable psychometric properties, and lack of copyright protection. However, all scales studied, except for the UPDRS Depression, are valid screening tools when PD-specific cutoff scores are used.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flow of participants through the Methods of Optimal Depression Detection in Parkinson's Disease (MOOD-PD) study
BDI = Beck Depression Inventory; CESD-R = Center for Epidemiologic Studies Depression Rating Scale–Revised; GDS-30 = 30-item Geriatric Depression Scale; IDS-SR = Inventory of Depressive Symptoms–Patient; MMSE = Mini-Mental State Examination; PD = Parkinson disease; PHQ-9 = Patient Health Questionnaire-9.
Figure 2
Figure 2. Mean depressive symptom rating scale scores by depressive disorder subgroup
Major depression >No active depression (all scales: p < 0 · 001). Nonmajor depression >No active depression (17-item Hamilton Depression Rating Scale [HAM-D-17], Inventory of Depressive Symptoms–Clinician [IDS-C]: p < 0 · 001; Beck Depression Inventory-II [BDI-II], Inventory of Depressive Symptoms–Patient [IDS-SR]: p < 0 · 002; Montgomery-Åsberg Depression Rating Scale [MADRS]: p < 0 · 005; 30-item Geriatric Depression Scale [GDS-30]: p > 0 · 011; Center for Epidemiologic Studies Depression Rating Scale–Revised [CESD-R]: p > 0 · 128; Patient Health Questionnaire-9 [PHQ-9]: p > 0 · 291; Unified Parkinson's Disease Rating Scale Depression [UPDRS-Dep]: p > 0 · 382). Major depression > Nonmajor depression (MADRS, PHQ-9, UPDRS-Dep: p < 0 · 001; HAM-D-17, IDS-C: p < 0 · 002; GDS-30: p < 0 · 006; CESD-R: p < 0 · 009; BDI-II: p < 0 · 046; IDS-SR: p < 0 · 060). CI = confidence interval.

Similar articles

Cited by

References

    1. Slaughter JR, Slaughter KA, Nichols D, Holmes SE, Martens MP. Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001; 13: 187– 196 - PubMed
    1. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002; 8: 193– 197 - PubMed
    1. O'Connor EA, Whitlock EP, Beil TL, Gaynes BN. Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med 2009; 151: 793– 803 - PubMed
    1. Schrag A, Barone P, Brown RG, et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2007; 22: 1077– 1092 - PMC - PubMed
    1. Marsh L, McDonald WM, Cummings J, Ravina B. Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group. Mov Disord 2006; 21: 148– 158 - PubMed

Publication types